Neomycin And Polymyxin B Sulfate And Bacitracin Zinc

   
Google
 
Web NewDrugInformation.com

Neomycin And Polymyxin B Sulfate And Bacitracin Zinc


Drug - Neomycin And Polymyxin B Sulfate And Bacitracin Zinc
The trade name of the product as shown on the labeling.

Dosage - OINTMENT; OPHTHALMIC
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Bacitracin Zinc; Neomycin Sulfate; Polymyxin B Sulfate
Multiple ingredients are in alphabetical order.

Strength - 400 UNITS/GM;EQ 3.5MG BASE/GM;10,000 UNITS/GM
The potency of the active ingredient(s), Bacitracin Zinc; Neomycin Sulfate; Polymyxin B Sulfate. May repeat for multiple part products.

Applicant - AKORN
The firm name holding legal responsibility for Neomycin And Polymyxin B Sulfate And Bacitracin Zinc. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 065088
The FDA assigned number to Neomycin And Polymyxin B Sulfate And Bacitracin Zinc. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Neomycin And Polymyxin B Sulfate And Bacitracin Zinc. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AT
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Feb 6, 2004
The date Neomycin And Polymyxin B Sulfate And Bacitracin Zinc was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Neomycin And Polymyxin B Sulfate And Bacitracin Zinc. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Neomycin And Polymyxin B Sulfate And Bacitracin Zinc is in. Format is RX, OTC, DISCN.

Applicant Full Name - Akorn Inc
The full name of the firm holding legal responsibility for the new application of Neomycin And Polymyxin B Sulfate And Bacitracin Zinc.

Neomycin And Polymyxin B Sulfate And Bacitracin Zinc


Zinc Bacitracin,neomycin Sulfate,polymyxin B Sulfate & Hydrocortisone 400 Units/gm;1%;eq 3.5mg Base/gm;10,000 Units/gm Ointment; Ophthalmic
Cortisporin 400 Units/gm;1%;eq 3.5mg Base/gm;5,000 Units/gm Ointment; Topical
Neomycin & Polymyxin B Sulfates & Bacitracin Zinc & Hydrocortisone 400 Units/gm;1%;eq 3.5mg Base/gm;5,000 Units/gm Ointment; Topical
Lanabiotic 400 Units/gm;40mg/gm;eq 5mg Base/gm;5,000 Units/gm Ointment; Topical
Bacitracin Zinc-neomycin Sulfate-polymyxin B Sulfate 400 Units/gm;eq 3.5mg Base/gm;10,000 Units/gm Ointment; Ophthalmic
Bacitracin-neomycin-polymyxin 400 Units/gm;eq 3.5mg Base/gm;10,000 Units/gm Ointment; Ophthalmic
Bacitracin-neomycin-polymyxin 400 Units/gm;eq 3.5mg Base/gm;5,000 Units/gm Ointment; Ophthalmic
Neomycin And Polymyxin B Sulfate And Bacitracin Zinc 400 Units/gm;eq 3.5mg Base/gm;10,000 Units/gm Ointment; Ophthalmic
Cortisporin 400 Units/gm;1%;eq 3.5mg Base/gm;10,000 Units/gm Ointment; Ophthalmic
Neomycin And Polymyxin B Sulfates, Bacitracin Zinc And Hydrocortisone 400 Units/gm;1%;eq 3.5mg Base/gm;10,000 Units/gm Ointment; Ophthalmic

NewDrugInformation